Bioavailability and bioactivity of intravenous vs subcutaneous infusion of growth hormone in GH-deficient patients

Clinical Endocrinology

Volumn 45, Issue 3, 1996, Pages 333-339

  Laursen, Torben ^a   Møller, Jens ^a   Jørgensen, Jens O L ^a   Ørskov, Hans ^a   Christiansen, Jens S ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ADULT; ARTICLE; BIOAVAILABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ADMINISTRATION; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029815180     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.00814.x     Document Type: Article

References (17)

1. Davidson, M.B. (1987) Effects of growth hormone on carbohydrate and lipid metabolism. Endocrine Review, 8, 115-131.
2. Frystyk, J., Dinesen, B. & Orskov, H. (1995) Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II. Growth Regulation, 5, 169-176.
3. Holl, R.W., Schwarz, U., Schauwecker, P., Benz, R., Veldhuis, J.D. & Heinze, E., (1993) Diurnal variation in the elimination rate of human growth hormone (GH): The half-life of serum GH is prolonged in the evening, and affected by the source of the hormone, as well as by body size and serum estradiol. Journal of Clinical Endocrinology and Metabolism, 77, 216-220.
4. Jørgensen, J.O. (1991) Human growth hormone replacement therapy: pharmacological and clinical aspects. Endocrine Review, 12, 189-207.
5. Jørgensen, J.O., Flyvbjerg, A., Dinesen, J., Lund, H., Alberti, K.G., Ørskov, H. & Christiansen, J.S. (1987) Serum profiles and short-term metabolic effect of pituitary and authentic biosynthetic human growth hormone in man. A double-blind cross-over study. Acta Endocrinolica Copenhagen, 116, 381-386.
6. Jøregensen, J.O., Flyvbjerg, A., Lauritzen, T., Ørskov, H. & Christiansen, J.S. (1988) Subcutaneous degradation of biosynthetic human growth hormone in growth hormone deficient patients. Acta Endocrinolica Copenhagen, 118, 154-158.
7. Jørgensen, J.O., Flyvbjerg, A. & Christiansen, J.S. (1989) The metabolic clearance rate, serum half-time and apparent distribution space of authentic biosynthetic human growth hormone in growth hormone-deficient patients. Acta Endocrinolica Copenhagen, 120, 8-13.
8. Jørgensen, J.O., Blum, W.F., Møller, N., Ranke, M.B. & Christiansen, J.S. (1991) Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients. Journal of Clinical Endocrinology and Metabolism, 72, 582-587.
9. Juul, A., Main, K., Blum, W.F., Lindholm, J., Ranke, M.B. & Skakkebaek, N.E. (1994) The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2, 3) decreases with age in healthy adults and is increased in acromegalic patients. Clinical Endocrinology, 41, 85-93.
10. Kastrup, K.W., Christiansen, J.S., Andersen, J.K. & Ørskov, H. (1983) Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient children. Acta Endocrinolica Copenhagen, 104, 148-152.
11. Laursen, T., Jørgensen, J.O. & Christiansen, J.S. (1994a) Metabolic response to growth hormone (GH) administered in a pulsatile, continuous or combined pattern. Endocrinology and Metabolism, 1, 33-40.
12. Laursen, T., Jørgensen, J.O.L., & Christiansen, J.S. (1994b) Metabolic effects of growth hromone administered subcutaneously once or twice daily to growth hormone deficient adults. Clinical Endocrinology, 41, 337-343.
13. MacGillivray, M.H., Frohman, L.A. & Doe, J. (1970) Metabolic clearance and production rates of human growth hormone in subjects with normal and abnormal growth. Journal of Clinical Endocrinology, 30, 632-638.
14. Møller, J., Jørgensen, J.O., Laursen, T., Frystysk, J., Naeraa, R.W., Ørskov, H. & Christiansen, J.S. (1993) Growth hormone dose regimens in adult GH deficiency: Effects on biochemical growth markers and metabolic parameters. Clinical Endocrinology, 39, 403-408.
15. Ørskov, H., Thomsen, H.G. & Yde, H. (1968) Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature, 219, 193-195.
16. Ranke, M.B., Blum, W.F., & Bierich, J.R. (1988) Clinical relevance of serum measurements of insulin-like growth factors and somatomedin binding proteins. Acta Paediatrica Scandinavica. [Suppl.] 347, 114-126.
17. Salomon, F., Cuneo, R.C. Hesp, R. & Sonksen, P.H. (1989) The effects of treatment with recombinant human growth hormone (GH) on body composition and metabolism in adults with GH deficiency. New England Journal of Medicine, 321, 1797-1803.